Stem cell transplant without radiation or chemotherapy pre-treatment shows promise

Researchers at Dana-Farber/Boston Children’s Cancer and Blood Disorders Center report promising outcomes from a clinical trial with patients with a rare form of bone marrow failure who received a hematopoietic stem cell transplant after pre-treatment with immunosuppressive drugs only. This is the first trial reporting successful transplant in dyskeratosis congenita patients without the use of any radiation or conventional cytotoxic chemotherapy beforehand. The trial’s data were presented at the annual meeting of the American Society of Hematology. —> Read More Here


Leave a Reply

Your email address will not be published. Required fields are marked *